FY2018 EPS Estimates for LONZA GRP AG/ADR Reduced by Analyst (LZAGY)
LONZA GRP AG/ADR (OTCMKTS:LZAGY) – Stock analysts at Jefferies Financial Group lowered their FY2018 EPS estimates for shares of LONZA GRP AG/ADR in a report issued on Monday, November 12th. Jefferies Financial Group analyst P. Welford now forecasts that the company will earn $1.26 per share for the year, down from their previous estimate of $1.28. Jefferies Financial Group also issued estimates for LONZA GRP AG/ADR’s FY2019 earnings at $1.39 EPS, FY2020 earnings at $1.57 EPS and FY2021 earnings at $1.79 EPS.
Separately, Zacks Investment Research downgraded LONZA GRP AG/ADR from a “hold” rating to a “sell” rating in a report on Tuesday, October 30th.
LONZA GRP AG/ADR Company Profile
Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and specialty ingredients markets worldwide. The company operates through two segments, Pharma&Biotech and Specialty Ingredients. It offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to dosage forms for the pharma and consumer health, and nutrition industries, as well as develops cell and gene therapies.
Further Reading: Trading Penny Stocks
Receive News & Ratings for LONZA GRP AG/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LONZA GRP AG/ADR and related companies with MarketBeat.com's FREE daily email newsletter.